MOORE ALISON 4
4 · Artiva Biotherapeutics, Inc. · Filed Oct 22, 2024
Insider Transaction Report
Form 4
MOORE ALISON
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2024-10-21+27,500→ 27,500 totalExercise: $10.48Exp: 2034-10-20→ Common Stock (27,500 underlying)
Footnotes (1)
- [F1]One-third of the shares vested following the grant date, with the remaining shares vesting monthly over an additional two years following October 21, 2024,